Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines

被引：1
|
作者：
Sanchez de Prada, Laura [1 ]
Sanz Munoz, Ivan [2 ]
Castrodeza Sanz, Javier [1 ]
Ortiz de Lejarazu Leonardo, Raul [2 ]
Eiros Bouza, Jose Maria [2 ,3 ]
机构：
[1] Univ Valladolid, Hosp Clin, Valladolid 47003, Spain
[2] Ctr Nacl Gripe Valladolid, Valladolid 47009, Spain
[3] Hosp Univ Rio Hortega Valladolid, Valladolid 47012, Spain
来源：
VACCINES | 2020年 / 8卷 / 04期
关键词：
influenza A; Vaccines; adjuvanted Vaccines; SEASONAL INFLUENZA; INFECTION; VACCINATION; MORTALITY;
D O I：
10.3390/vaccines8040704
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Background: vaccination is the best approach to prevent influenza infections so far. Serological studies on the effect of different vaccine types are important to address vaccination campaigns and protect our population. In our study, we compared the serological response against influenza A subtypes using the non-adjuvanted influenza vaccine (NAIV) in adults and the elderly and the adjuvanted influenza vaccine (AIV) in the elderly. Methods: We performed a retrospective analysis by hemagglutination inhibition assay (HI) of serum samples right before and 28 days after seasonal influenza vaccination during the 1996-2017 seasons. Conclusions: The AIV presents better performance against the A(H3N2) subtype in the elderly whereas the NAIV induces a better response against A(H1N1)pdm09 in the same group.
引用
收藏
页码：1 / 11
页数：11
相关论文
共 50 条
  • [41] A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration
    Della Cioppa, Giovanni
    Nicolay, Uwe
    Lindert, Kelly
    Leroux-Roels, Geert
    Clement, Frederic
    Castellino, Flora
    Galli, Grazia
    Groth, Nicola
    Levin, Yotam
    Del Giudice, Giuseppe
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (06) : 1701 - 1710
  • [42] Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines
    Sanchez, Pedro L.
    Andre, Greiciely
    Antipov, Anna
    Petrovsky, Nikolai
    Ross, Ted M.
    VACCINES, 2024, 12 (05)
  • [43] Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines
    Sanchez, Pedro L.
    Staats, Herman F.
    Abraham, Soman N.
    Ross, Ted M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [44] Adjuvanted versus non-adjuvanted standard-dose influenza vaccines in preventing all-cause hospitalizations in the elderly: a cohort study with nested case-control analyses over 18 influenza seasons
    Lapi, Francesco
    Domnich, Alexander
    Marconi, Ettore
    Rossi, Alessandro
    Cricelli, Claudio
    EXPERT REVIEW OF VACCINES, 2022, 21 (11) : 1647 - 1653
  • [45] Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis
    Sampaio-Barros, Percival D.
    Andrade, Danieli C. O.
    Seguro, Luciana C. P.
    Pasoto, Sandra G.
    Viana, Vilma S. T.
    Ribeiro, Ana C. M.
    Aikawa, Nadia E.
    Timenetsky, Maria do Carmo S.
    Precioso, Alexander R.
    Silva, Clovis A.
    Bonfa, Eloisa
    RHEUMATOLOGY, 2018, 57 (10) : 1721 - 1725
  • [46] Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines
    Thueng-in, Kanyarat
    Maneewatch, Santi
    Srimanote, Potjanee
    Songserm, Thaweesak
    Tapchaisri, Pramuan
    Sookrung, Nitat
    Tongtawe, Pongsri
    Channarong, Sunee
    Chaicumpa, Wanpen
    VACCINE, 2010, 28 (41) : 6765 - 6777
  • [47] Cross-protection by MF59™-adjuvanted influenza vaccine:: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
    Ansaldi, Filippo
    Bacilieri, Sabrina
    Durando, Paolo
    Sticchi, Laura
    Valle, Laura
    Montomoli, Ernanuele
    Icardi, Giancarlo
    Gasparini, Roberto
    Crovari, Pietro
    VACCINE, 2008, 26 (12) : 1525 - 1529
  • [48] Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin
    Basha, Saleem
    Hazenfeld, Staci
    Brady, Rebecca C.
    Subbramanian, Ramu A.
    HUMAN IMMUNOLOGY, 2011, 72 (06) : 463 - 469
  • [49] Antibody response against heterogeneous circulating influenza virus strains elicited by MF59-and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
    Ansaldi, Filippo
    Zancolli, Marta
    Durando, Paolo
    Montomoli, Emanuele
    Sticchi, Laura
    Del Giudice, Giuseppe
    Icardi, Giancarlo
    VACCINE, 2010, 28 (25) : 4123 - 4129
  • [50] Intanza® 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses
    Ansaldi, Filippo
    Canepa, Paola
    Ceravolo, Antonella
    Valle, Laura
    de Florentiis, Daniela
    Oomen, Raymond
    Vogel, Frederick R.
    Denis, Martine
    Samson, Sandrine I.
    Icardi, Giancarlo
    VACCINE, 2012, 30 (18) : 2908 - 2913
12345